Markets & Economy Scholar Rock Shares Rise 9.1% After FDA Approves ISEMBYLD for Spinal Muscular Atrophy September 14, 2026 · 12:08 pm 1 sources Image: Yahoo Finance ad slot · in-content video 16:9 Coverage More coverageScholar Rock Shares Rise 9.1% After FDA Approves ISEMBYLD for Spinal Muscular AtrophyYahoo Finance · September 14, 2026 12:08
